Industry Veteran and Former Pfizer Chief Scientific Officer Brings Extensive R&D and Leadership Experience to Advance BenchSci's Mission of Improving the Speed and Quality of Preclinical R&D ...

Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the 3SBio’s SSGJ-707.

HBCU Fellow Tre’von Conner shares how the IKNS curriculum at Columbia is helping him learn how to effectively tackle ...

MSD has joined fellow big pharmas in looking to redirect cash, as the drugmaker revealed plans to save $3bn annually by the end of 2027.

The International Chamber of Commerce (ICC), the world business organization representing more than 4.5-million-member ...

SmallCap stocks can often be overlooked by institutional investors, yet they offer outsized return potential for those ...

Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

Procter & Gamble said on Monday CEO Jon Moeller is stepping away from the top job after four years in the role, and that he would be succeeded by Chief Operating Officer Shailesh Jejurikar.

At the recent 2025 AHA Leadership Summit, the Advancing Innovation Showcase offered a rapid-fire glimpse into the future of care delivery, workforce support and digital transformation.